About Keratin, type I cytoskeletal 16
Keratin, type I cytoskeletal 16 (KRT16) is a protein
from Homo sapiens identified by UniProt accession
P08779, 473 residues long.
MolForge cross-references it against 0 known binders and
173 disease associations.
Target properties
| Protein name | Keratin, type I cytoskeletal 16 |
| UniProt accession | P08779 |
| Gene | KRT16 |
| Organism | Homo sapiens |
| Length | 473 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (173)
Diseases linked to this target (Open Targets).
- pachyonychia congenita · score 0.71
- Non-epidermolytic palmoplantar keratoderma · score 0.69
- focal palmoplantar keratoderma · score 0.52
- genetic disorder · score 0.19
- glioblastoma multiforme · score 0.19
- head and neck squamous cell carcinoma · score 0.19
- prostate adenocarcinoma · score 0.18
- clear cell renal carcinoma · score 0.18
- breast adenocarcinoma · score 0.18
- Localized epidermolytic hyperkeratosis · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P08779-F1 | alphafold | PREDICTED | 71.54 | — |
Amino-acid sequence (473 residues)
MTTCSRQFTS SSSMKGSCGI GGGIGGGSSR ISSVLAGGSC RAPSTYGGGL SVSSRFSSGG ACGLGGGYGG GFSSSSSFGS GFGGGYGGGL GAGFGGGLGA GFGGGFAGGD GLLVGSEKVT MQNLNDRLAS YLDKVRALEE ANADLEVKIR DWYQRQRPSE IKDYSPYFKT IEDLRNKIIA ATIENAQPIL QIDNARLAAD DFRTKYEHEL ALRQTVEADV NGLRRVLDEL TLARTDLEMQ IEGLKEELAY LRKNHEEEML ALRGQTGGDV NVEMDAAPGV DLSRILNEMR DQYEQMAEKN RRDAETWFLS KTEELNKEVA SNSELVQSSR SEVTELRRVL QGLEIELQSQ LSMKASLENS LEETKGRYCM QLSQIQGLIG SVEEQLAQLR CEMEQQSQEY QILLDVKTRL EQEIATYRRL LEGEDAHLSS QQASGQSYSS REVFTSSSSS SSRQTRPILK EQSSSSFSQG QSS
Explore Keratin, type I cytoskeletal 16 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets